Assessment of an Intervention to Reduce Aspirin Prescribing for Patients Receiving Warfarin for Anticoagulation

Aspirin Use to Prevent Cardiovascular Disease

(2022) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antithrombosis stewardship efforts to de-escalate inappropriate combined therapy in outpatient clinics

(2021) Siena Meador et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Evaluation and optimization of prescribed concomitant antiplatelet and anticoagulation therapy centrally managed by an anticoagulation management service

(2020) Sara A. Zekery-Saad et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Association of Adding Aspirin to Warfarin Therapy Without an Apparent Indication With Bleeding and Other Adverse Events

(2019) Jordan K. Schaefer et al.   JAMA Internal Medicine

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

(2019) Donna K. Arnett et al.   CIRCULATION

The rise and fall of aspirin in the primary prevention of cardiovascular disease

(2019) Inbar Raber et al.   LANCET

Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey

(2019) Colin W. O'Brien et al.   ANNALS OF INTERNAL MEDICINE

Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2016) Kirsten Bibbins-Domingo et al.   ANNALS OF INTERNAL MEDICINE

2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

(2016) Marie D. Gerhard-Herman et al.   CIRCULATION

Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants

(2016) Geoffrey D. Barnes et al.  

Combined aspirin and anticoagulant therapy in patients with atrial fibrillation

(2016) Charlotte H. So et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants

(2016) Geoffrey D. Barnes et al.   Circulation-Cardiovascular Quality and Outcomes

Aspirin Use Among Adults in the U.S.

(2015) Craig D. Williams et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

(2015) S. Kaatz et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Engaging with quality improvement in anticoagulation management

(2015) Geoffrey D. Barnes et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

(2014) Rick A. Nishimura et al.   CIRCULATION

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

(2014) Walter N. Kernan et al.   STROKE

Use and Associated Risks of Concomitant Aspirin Therapy With Oral Anticoagulation in Patients With Atrial Fibrillation

(2013) Benjamin A. Steinberg et al.   CIRCULATION

Antithrombotic Therapy for Atrial Fibrillation

(2012) John J. You et al.   CHEST

Antithrombotic and Thrombolytic Therapy for Ischemic Stroke

(2012) Maarten G. Lansberg et al.   CHEST

Antithrombotic and Thrombolytic Therapy for Valvular Disease

(2012) Richard P. Whitlock et al.   CHEST

Antithrombotic Therapy in Peripheral Artery Disease

(2012) Pablo Alonso-Coello et al.   CHEST

Primary and Secondary Prevention of Cardiovascular Disease

(2012) Per Olav Vandvik et al.   CHEST

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary

(2012) Stephan D. Fihn et al.   CIRCULATION

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary

(2012) Patrick T. O’Gara et al.   CIRCULATION

Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?

(2011) James D. Douketis   THROMBOSIS RESEARCH

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

(2010) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?

(2009) Marco P. Donadini et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Outcomes Associated With Combined Antiplatelet and Anticoagulant Therapy

(2008) Samuel G. Johnson et al.   CHEST